↓ Skip to main content

Dove Medical Press

Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?

Overview of attention for article published in Clinical Interventions in Aging, November 2009
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
23 Mendeley